Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.

British journal of cancer - 5 May 2009

Gronwald J, Cybulski C, Piesiak W, Suchy J, Huzarski T, Byrski T, Gorski B, Debniak T, Szwiec M, Wokolowczyk D, Matuszewski M, Sun P, Lubinski J, Narod S A

Abstract excerpt

It is important to have accurate knowledge of the range of cancers associated with various CHEK2 mutations, and of the lifetime risks of cancer associated with each. We wished to establish the relationship between family history, mutation type and cancer risk in families with a CHEK2 mutation. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier State
Share to Checkpoint Kinase 2
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Family

Share to Genetic Carrier Screening

Share to Neoplasms

Share to Prostatic Neoplasms

Share to Protein Serine-Threonine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 19401704
DOI: 10.1038/sj.bjc.6605038
PMCID: PMC2694428

Genes

CHEK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19401704-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.PMID 19401704Read ↗

Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Semantic proximity Read ↗

CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.Semantic proximity Read ↗

Genomic ascertainment of<i>CHEK2</i>-related cancer predispositionSemantic proximity Read ↗

Genomic Ascertainment of CHEK2-Related Cancer Predisposition.Semantic proximity Read ↗

Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.Semantic proximity Read ↗

Breast cancer risk associated with CHEK2 mutations.Semantic proximity Read ↗

Cancer spectrum in Mexican patients with the CHEK2 p.(Leu236Pro) variant: a retrospective study.Semantic proximity Read ↗

CHEK2 is a multiorgan cancer susceptibility gene.Semantic proximity Read ↗

Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing.Semantic proximity Read ↗

Is CHEK2 a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?Semantic proximity Read ↗

Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.Semantic proximity Read ↗

Mutations in CHEK2 associated with prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.